EPO and malaria: In line with these findings, in our study, on day 12 p.i., both VIT-treated and untreated groups exhibited elevated serum EPO levels, with a more marked increase in the VIT-treated group, suggesting a compensatory erythropoietic response to heightened malaria severity and anemia.